Does Profhilo Work? An Evidence Review of the Injectable Skin Booster

Profhilo is an injectable "skin booster" made from pure hyaluronic acid that promises firmer, more hydrated, better-quality skin rather than the line-erasing or volumizing effects of Botox and traditional fillers. The marketing is confident, the before-and-after photos are striking, and the treatment has been used on hundreds of thousands of people since 2015. This review walks through what Profhilo actually is, what the published clinical evidence shows, how strong that evidence really is, and where it fits next to the alternatives you can legally get in the United States.

What Profhilo Actually Is

Profhilo is an injectable medical device made by the Italian company IBSA. It contains hyaluronic acid (HA), the same sugar-based molecule your skin makes naturally to hold water and keep tissue plump. Each 2 mL syringe holds 64 mg of HA: 32 mg of high-molecular-weight HA (around 1,100–1,400 kilodaltons) and 32 mg of low-molecular-weight HA (around 80–100 kilodaltons).

What makes Profhilo different from a standard HA filler is how those two forms are combined. Instead of using a chemical cross-linker called BDDE, which traditional fillers rely on to stay put, Profhilo uses a heat-based process the company calls NAHYCO technology. This binds the two HA types into a "hybrid cooperative complex." The result is a product that spreads through the skin rather than holding a fixed shape.

That distinction matters. A filler is designed to sit in one place and add volume or structure. Profhilo is designed to do the opposite: flow under the skin, hydrate a broad area, and, according to the manufacturer, signal skin cells to make more collagen and elastin over time. The industry calls this "bio-remodelling." It is marketed as skin-quality treatment, not a wrinkle filler.

Profhilo is usually injected at five specific points on each side of the face (a method called the BAP technique, for Bio Aesthetic Points), chosen to be safe and to let the product diffuse widely. The standard course is two sessions, one month apart, with maintenance every six months or so.

A Critical Caveat for US Readers

Profhilo is not approved by the US Food and Drug Administration. It is CE-marked and widely used across Europe, the UK, the Middle East, and parts of Asia, but it cannot be legally sold or injected in the United States. If a US clinic offers "Profhilo," that is a red flag worth questioning. The closest FDA-cleared product available in the US is SkinVive by Juvederm, which is a different formulation. We cover the alternatives in detail below.

This review evaluates the global evidence on Profhilo. It is not a recommendation to seek out an unapproved product.

How It's Supposed to Work

The proposed mechanism has two parts.

First, hydration. Hyaluronic acid binds water. Spreading 64 mg of it through the dermis draws in moisture and, in the short term, makes skin look dewier and feel firmer. This part is uncontroversial. HA holds water; that is basic biochemistry.

Second, bio-remodelling. This is the bigger and more interesting claim. Laboratory studies on skin cells suggest that the slow breakdown of Profhilo's HA blend can nudge fibroblasts (the cells that build skin's support structure) to produce more collagen and elastin, and may encourage some fat and skin cells to behave in younger ways. The idea is that the product does not just plump tissue with water but kicks off a remodelling process that improves the underlying scaffolding of the skin.

The hydration effect is well-established. The bio-remodelling effect is biologically plausible and supported by lab work and by skin-elasticity measurements in human studies, but the human evidence is thinner and less rigorous than the marketing implies. That gap between mechanism and proof is the central theme of this review.

It helps to understand why the two-HA blend is the selling point. High-molecular-weight HA holds a lot of water and tends to calm inflammation, but it breaks down slowly and does not signal cells much on its own. Low-molecular-weight HA breaks down faster and is more biologically active, but on its own it can be more inflammatory. By binding the two together with heat instead of a chemical cross-linker, the manufacturer says you get a longer, steadier release of the active fragments without the irritation, in theory giving cells a gentle, sustained nudge to remodel. That is the mechanistic story. Whether it translates into meaningfully more collagen in living human skin, over months, compared to doing nothing, is exactly what the human trials have not yet proven at scale.

What the Evidence Actually Shows

Here is the honest picture. Profhilo has a fair amount of published clinical literature, but the quality is uneven. Most studies are small, open-label (meaning everyone knew they were getting the treatment, with no blinding), and many were funded or co-authored by the manufacturer. There is exactly one published placebo-controlled randomized trial, and it enrolled only 12 people. That is the strongest study design in the bunch, and it is tiny.

The table below summarizes the key published studies and how much weight each one can bear.

Reading the Strongest Study Honestly

The 2026 triple-blind, placebo-controlled split-face trial deserves attention because it is the only one designed to separate a real drug effect from wishful thinking. Each participant got Profhilo on one side of the mouth area and saline (a placebo) on the other, and neither the patient, the injector, nor the assessor knew which was which. Standardized photos showed visible improvement in wrinkles and pores on the Profhilo side, and the blinded design is genuinely good. But the result that matters most cuts the other way: ultrasound showed dermal thickness increased on both the Profhilo side and the saline side, and the authors concluded the Profhilo effect on dermal thickness did not exceed placebo. Patient satisfaction was also poor, with many participants unhappy with the outcome. So the one rigorous trial actually failed to show that Profhilo beats placebo on its core structural claim.

And twelve people is a very small sample. With numbers that small, findings can be real or can be chance, and the results need to be reproduced in larger trials before anyone treats them as settled. One small RCT is a starting point, not a verdict.

What the Open-Label Studies Can and Cannot Tell You

The bigger studies (64 faces, 23 necks) consistently report improvements in measured skin elasticity, hydration, and wrinkle severity. The numbers are not trivial. But none of these studies used a placebo or blinding, so they cannot rule out the powerful placebo effect that runs through all cosmetic procedures, nor the simple fact that people who pay for and expect a result tend to rate themselves as improved. Measured skin elasticity by instrument is harder to fake than self-rating, and that is the more persuasive part of these studies. Still, "no control group" is a real limitation, not a footnote.

The Manufacturer-Funding Problem

The 2026 systematic review pulled together nine studies and 278 participants and concluded that Profhilo consistently improved skin elasticity, hydration, density, laxity, and facial volume loss, with mild and short-lived side effects. That sounds strong. The catch: three of the review's authors are employees of IBSA, the company that makes Profhilo. That does not make the findings false. It does mean an independent reviewer would weigh them more cautiously, and it is a conflict of interest worth knowing about. A review can only be as good as the studies inside it, and most of those studies were small and uncontrolled.

Our Honest Grade

The hydration and short-term skin-quality benefits of Profhilo are reasonably well-supported. The deeper "bio-remodelling, builds new collagen, lasting structural change" claim is plausible and pointed in the right direction by the evidence, but it has not been proven by the kind of large, independent, placebo-controlled trials that would settle it. Grade: promising, with real but modest and not-yet-definitive evidence. Better than nothing, weaker than the marketing.

Profhilo vs. The Alternatives

Profhilo sits in a crowded space. Because it is not available in the US, the comparison matters most for deciding what to actually do. Here is how it stacks up against the main options.

SkinVive is the closest legal US substitute. It is also pure HA aimed at skin quality rather than volume, and it cleared an FDA pivotal trial. If you are in the US and the Profhilo concept appeals to you, SkinVive is the realistic, approved version of that idea.

Traditional fillers do something genuinely different. If your goal is to restore lost cheek volume or lift, a filler does that and Profhilo does not. They are not interchangeable.

Microneedling and polynucleotide treatments chase the same "remodel and regenerate the skin" promise from different angles. Microneedling has a longer evidence track record; polynucleotides are newer and even less proven than Profhilo.

Topical retinoids are the unglamorous, best-evidenced collagen booster available. They cost a fraction of any injectable and have decades of trials behind them. For many people chasing skin quality, a prescription retinoid plus sunscreen will do more, for less, than a seasonal injectable.

For broader context on how injectables compare on cost and longevity, see our Botox vs. dermal fillers comparison and our injectables guide.

Safety and Side Effects

On safety, the evidence is actually reassuring, and it is the strongest part of Profhilo's record. The 2020 worldwide postmarketing review looked at every spontaneous adverse-event report filed over the product's first three years, covering more than 40,000 treated patients, and found just 12 reports, none of them serious. That is a very low rate.

The most common reactions are the predictable ones for any injection:

• Early, short-term: redness, swelling, mild bruising, and small bumps at the injection points, usually fading within hours to a few days.
• Less common: firmer or longer-lasting nodules, which the safety literature largely attributed to injection technique or individual hypersensitivity rather than the product itself.

Serious complications are rare, and the major adverse events that worry doctors with thicker fillers (such as vascular occlusion from blocking a blood vessel) are less of a concern with a thin, spreading product like Profhilo injected at standardized safe points. Still, any injectable carries a small risk of infection, allergic reaction, or vascular injury, and technique matters enormously.

The bigger safety issue for US readers is not the product chemistry. It is that an unapproved injectable obtained through gray-market channels has no quality guarantee, and a provider willing to use it may be cutting other corners too. Sourcing and provider credentials are where the real risk lives.

A few practical safety pointers apply wherever you are. Stop blood-thinning supplements like fish oil and high-dose vitamin E for a few days beforehand if your doctor agrees, since they raise bruising risk. Expect small raised bumps at the injection points right after treatment; these are the deposited product and normally settle within a day. Avoid heavy exercise, alcohol, saunas, and makeup over the sites for the first 24 hours. And ask, plainly, who is doing the injecting and what their training is. A licensed physician, nurse injector, or appropriately trained practitioner with real experience is non-negotiable for any needle in the face.

What It Costs

In markets where it is sold legally, Profhilo typically runs a few hundred dollars (or pounds) per session, and the standard starting course is two sessions, so budget for the pair up front plus maintenance roughly twice a year. That recurring cost is worth weighing against alternatives. A prescription retinoid costs a tiny fraction of one session and works continuously. SkinVive, the FDA-cleared US option, is priced in a similar range to other skin boosters. Because Profhilo is a maintenance treatment rather than a one-time fix, the real number to consider is the annual cost over several years, not the price of a single visit.

Who Profhilo Is (and Isn't) For

Profhilo is positioned for people who want to improve overall skin quality, hydration, firmness, and texture, rather than fill a specific line or restore lost volume. It tends to be marketed to people in their late 30s through 50s who have early skin laxity and dullness but do not yet want, or do not need, structural filler.

It is a reasonable fit if you:

• Want a subtle, "skin looks healthier" result rather than a dramatic change
• Have mild skin laxity, crepiness, or dehydration
• Understand it is a maintenance treatment, not a one-time fix
• Are being treated somewhere it is legally and properly available

It is a poor fit if you:

• Want to correct deep folds or restore facial volume (you want filler, or other options)
• Expect Botox-level wrinkle smoothing (Profhilo does not relax muscles)
• Are in the US and would have to source an unapproved product
• Are pregnant, breastfeeding, or have an active skin infection at the site
• Expect proven, dramatic, permanent collagen rebuilding (the evidence does not support that)

If your main concern is firmness and skin tightening rather than hydration, energy-based options may be a better-evidenced route; see our reviews on whether Ultherapy works and whether Morpheus8 works. And if you are weighing a regenerative HA-style injectable, our polynucleotide (salmon DNA) evidence review covers a close cousin to Profhilo.

The Bottom Line

Profhilo is a real product with a coherent scientific idea behind it and a strong safety record. The hydration and short-term skin-quality benefits are reasonably well-supported. The headline promise, that it rebuilds collagen and remodels your skin's structure, is plausible and pointed at by lab work and instrument-based elasticity readings, but it has not been proven by larger, independent, blinded studies; in fact the one small placebo-controlled trial found Profhilo did not beat placebo on dermal thickness, so the structural claim remains unproven. Most of the human evidence is small, uncontrolled, and manufacturer-linked.

For US readers, the practical reality is simpler: Profhilo is not FDA-approved, cannot be legally administered here, and the approved alternative built on the same concept is SkinVive. Treat any US clinic offering Profhilo with skepticism. Wherever you are, go in with calibrated expectations: this is a subtle, temporary skin-quality treatment, not a structural overhaul, and the science is encouraging rather than conclusive.

Frequently Asked Questions

Is Profhilo FDA-approved in the United States?

No. As of 2026, Profhilo is not approved by the FDA and cannot be legally sold or injected in the US. It is CE-marked and used widely in Europe, the UK, and elsewhere. The closest FDA-cleared product based on the same skin-booster idea is SkinVive by Juvederm. A US clinic advertising Profhilo is a warning sign worth questioning.

How long does Profhilo last?

Most protocols treat Profhilo as a maintenance product. The standard course is two sessions a month apart, with results generally described as lasting around six months before a top-up is recommended. The hydration effect fades sooner than any longer-term skin-quality change the manufacturer claims. Longevity varies with age, skin condition, and how your body breaks down hyaluronic acid.

Does Profhilo really build collagen, or is that just marketing?

Laboratory studies on skin cells suggest Profhilo's hyaluronic acid blend can stimulate fibroblasts to make more collagen and elastin, and human studies have measured improvements in skin elasticity. So the claim is biologically plausible and pointed in the right direction. But it has not been confirmed by large, independent, placebo-controlled trials, so treat "builds collagen" as promising rather than proven.

Is Profhilo the same as a dermal filler?

No. A dermal filler is cross-linked to hold its shape and add volume or structure in one spot. Profhilo is not cross-linked with BDDE; it spreads through the skin to hydrate a broad area and aims to improve skin quality rather than add volume. If your goal is to restore lost cheek volume or lift, you want a filler, not Profhilo.

Is Profhilo safe?

The safety record is one of its strongest points. A worldwide review covering more than 40,000 treated patients over three years found only 12 adverse-event reports, none serious. Typical side effects are mild and short-lived: redness, swelling, bruising, and small bumps at the injection sites. The larger risk for US patients is sourcing an unapproved product from an unreliable provider, not the chemistry of the product itself.

This article is for general information only and is not medical advice. Profhilo is not FDA-approved for use in the United States. Talk to a licensed, qualified medical provider before considering any injectable treatment.

Sources

• 16-week open-label facial evaluation of HA hybrid cooperative complexes (PMID 27713647)
• Profhilo for neck skin roughness and laxity, open-label study (PMID 36164489)
• Triple-blind, placebo-controlled split-face RCT on perioral wrinkles (PMID 41731228)
• Open-label study in Asian patients (PMID 40921777)
• Systematic review of Profhilo efficacy and safety (PMID 41920062)
• Worldwide postmarketing safety assessment, 40,000+ patients (PMID 32685528)
• PubMed search: Profhilo clinical studies
• FDA: Dermal Fillers (Soft Tissue Fillers) overview